Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes. (Q48210503)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes. |
scientific article |
Statements
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes (English)
Cristina Auger
Carlos Nos
Mari C Edo
Joaquín Castilló
Alex Rovira
14 January 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference